1-10 of 10
Taha Merghoub, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Pilot Study Evaluating Lenalidomide and CC-486 in Combination with Radiotherapy for Patients with Plasmacytoma (LENAZART study)

Urvi A Shah, MD, Kelly Werner, RN, Elizabet Tavitian, BS, Sean Devlin, PhD, Sham Mailankody, MBBS, Neha Korde, MD, Malin Hultcrantz, MD PhD, Carlyn Tan, MD, Sydney X. Lu, MD PhD, Eric L Smith, MDPhD, Francesco Maura, MD, Dhwani Patel, MD, Gunjan L. Shah, MDMS, Oscar B Lahoud, MD, Michael Scordo, MD, Richard J Lin, MDPhD, Parastoo B. Dahi, MD, Heather J Landau, MD, David J. Chung, MD PhD, Hani Hassoun, MD, Jonathan Landa, MD, Bernard O'Malley, Christopher Barker, MD, Taha Merghoub, PhD, Sergio A. Giralt, MD, Ola Landgren, MD PhD, Joachim Yahalom, MD, Alexander M. Lesokhin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–10.
https://doi.org/10.1182/blood-2020-141131
Published: 2020
Journal Articles

Chromatin State Dynamics Underlying CD8 T Cell Differentiation and Dysfunction in Cancer

Mary Philip, MD PhD, Lauren Fairchild, Liping Sun, PhD, Agnes Viale, PhD, Taha Merghoub, PhD, Jedd D. Wolchok, MD PhD, Christina S. Leslie, PhD, Andrea Schietinger, PhD
Journal: Blood
Blood (2016) 128 (22): 861.
https://doi.org/10.1182/blood.V128.22.861.861
Published: 2016
Journal Articles

Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment

Alexander Lesokhin, MD, Tobias Hohl, MD, PhD, Taha Merghoub, PhD, Daniel Hirschhorn-cymerman, PhD, Eric G. Pamer, MD, Alan N Houghton, MD, Jedd D Wolchok, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2171.
https://doi.org/10.1182/blood.V118.21.2171.2171
Published: 2011
Journal Articles

Artificial Antigen Presenting Cells Expand NY-ESO-1 Antigen-Specific CD8+ T Cells From Patients with Melanoma

Marcela V. Maus, MD, PhD, Isabelle Riviere, PhD, Oriana Borquez-Ojeda, Xiuyan Wang, PhD, Jianda Yuan, MD, Taha Merghoub, PhD, Jason Plotkin, Richard J. O’Reilly, MD, Jedd D Wolchok, MD, PhD, Michel Sadelain, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4309.
https://doi.org/10.1182/blood.V118.21.4309.4309
Published: 2011
Journal Articles

TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation.

Il-Kang Na, MD, Sydney X Lu, PhD, Nury L. Yim, Gabrielle L. Goldberg, PhD, Jennifer Tsai, MD, Uttam K. Rao, Odette M. Smith, Christopher King, David Suh, Daniel Hirschhorn-Cymerman, PhD, Maria Lia Palomba, MD, Olaf Penack, MD, Amanda M. Holland, Robert R. Jenq, MD, Arnab Ghosh, MD, PhD, Hien Tran, MD, Taha Merghoub, PhD, Chen Liu, MD, Greg Sempowski, MD, Melissa Ventevogel, Nicole Beauchemin, PhD, Bruce Furie, MD, Marcel R.M. van den Brink, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 234.
https://doi.org/10.1182/blood.V114.22.234.234
Published: 2009
Journal Articles

The T Cell Cytolytic Molecules Fas Ligand and TRAIL, the Trafficking Molecules CCR9, β7 Integrin and PSGL-1, and the Immune Modulating Molecules OX40, CEACAM1, and CTLA4 Are Required for Thymic Graft-Versus-Host Disease

Il-Kang Na, MD, Sydney X. Lu, Gabrielle L. Goldberg, PhD, Daniel Daniel Hirschhorn-Cymerman, PhD, Christopher G. King, Odette M. Smith, David Suh, Uttam Rao, Nury Yim, Amanda M. Holland, Olaf Penack, MD, Robert R. Jenq, MD, Arnab Ghosh, MD, PhD, Laura Teisch, Simon Meykler, Janine Lin, Alejandro Sepulveda, PhD, Taha Merghoub, PhD, Alan Houghton, MD, Marcel R. M. van den Brink, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 65.
https://doi.org/10.1182/blood.V112.11.65.65
Published: 2008
Journal Articles

Synergistic Tumor Immunity Induced by Chemotherapy and Agonist Anti-GITR Antibody.

Adam D. Cohen, MD, Daniel Hirschhorn-Cymmerman, PhD, Adi Diab, MD, Miguel A. Perales, MD, Taha Merghoub, PhD, Jedd D. Wolchok, MD, PhD, Alan N. Houghton, MD
Journal: Blood
Blood (2007) 110 (11): 1788.
https://doi.org/10.1182/blood.V110.11.1788.1788
Published: 2007
Journal Articles

LRF/Pokemon Plays a Pivotal Role in B Versus T Lymphoid Lineage Fate Decision at the Early Lymphoid Progenitor Stage by Opposing Notch1 Signaling.

Takahiro Maeda, MD, PhD, Taha Merghoub, PhD, Lin Dong, MD, Manami Maeda, MD.PhD., Robin Hobbs, PhD, Johannes Zakrzewski, MD, Marcel van den Brink, MD.PhD., Hirokazu Shigematsu, MD.PhD., Koichi Akashi, MD.PhD., Arthur Zelent, PhD, Julie Teruya-Feldstein, MD, Giorgio Cattoretti, MD, Pier Paolo Pandolfi, MD.PhD.
Journal: Blood
Blood (2006) 108 (11): 778.
https://doi.org/10.1182/blood.V108.11.778.778
Published: 2006
Journal Articles

Conditional Inactivation of the Proto-Oncogene Pokemon Results in Block of Differentiation in Multiple Hematopoietic Lineages.

Takahiro Maeda, MD, PhD, Taha Merghoub, PhD, Robin Hobbs, PhD, Lin Dong, MD, Manami Maeda, MD, PhD, Arthur Zelent, PhD, Julie Teruya-Feldstein, MD, Pier Paolo Pandolfi, MD.PhD
Journal: Blood
Blood (2005) 106 (11): 121.
https://doi.org/10.1182/blood.V106.11.121.121
Published: 2005
Journal Articles

POKEMON Is a Proto-Oncogene Which Plays a Key Role in Lymphomagenesis.

Takahiro Maeda, MD, PhD, Robin Hobbs, PhD, Taha Merghoub, PhD, Ilhem Guernah, M.S, Arthur Zelent, PhD, Julie Teruya-Feldstein, MD, PhD, Pier Paolo Pandolfi, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3489.
https://doi.org/10.1182/blood.V104.11.3489.3489
Published: 2004